are glp-1 receptor agonists approved for type 1 diabetes fda FDA-Approved Dosages and Indications and Dual GIP/GLP-1 New GLP-1 Guidelines for Type

Crdova-Palomera A, et al

"Mutations of the flavin-containing monooxygenase gene ( FMO3 ) cause trimethylaminuria, a defect in detoxication"

Morello J, Derks RJE, Lopes SS, Steenvoorden E, Monteiro EC, Mayboroda OA et al (2018) Zebrafish larvae are a suitable model to investigate the metabolic phenotype of drug-induced renal tubular injury

During treatment, your provider may monitor: IGF-1 levels glucose and insulin response cholesterol markers liver function kidney function thyroid markers sex hormones blood pressure symptom changes sleep quality energy levels appetite recovery speed body composition skin quality workout performance side effects Monitoring allows your provider to adjust the dosage, change the treatment timeline, pause therapy if needed, or switch to a better-suited peptide based on how your body responds